Lauren Dong

PhD Graduate Student

Lauren Dong

Lab Phone


Start Year


Different combinations of MEK inhibitors and immune checkpoint blockade (ICB) are currently being explored in clinical trials, however their effects are still unclear. I am working to further understand the mechanism behind the effects of MEK inhibitors on immune cells and antigenicity. Balancing the negative and positive effects of MEK inhibition will determine the ideal agents and schedule to use for maximizing anti-tumor response.